Welcome To KAIMRC
Vision: To be a leading international institution in biomedical and clinical research.
Mission: To generate cutting-edge scientific research that helps improve the health of the population.

Closing Ceremony -
Riyadh Global Medical Biotechnology Summit 2021

Closing Ceremony - 12th Research Summer School 2021

Clinical Trials Unit

"When Participation becomes most

rewarding to improve health"

Clinical Trials Community Registration

Medical Biotechnology Park

"Making Economic Impact through

Innovative Medical R&D"

Drug Discovery

"Discovering New Medicines

for Better Health"

Saudi BioBank

"Improving the Health for future

generations through Medical Research"

Saudi Stem Cell Donor Registry

"Donate to save lives"

Research Training and Development

"Capacity Building Programs

for Smarter Generations"

RESEARCH AND DEVELOPMENT FOCUS AREAS

Blood and Cancer

• Breast Cancer
• Colorectal Cancer
• Leukemia
• Lymphoma
• Sickle Cell Disease

Diabetes and Metabolic Disorders

• Diabetes
• Obesity

Cardiovascular Diseases

• Ischemic Heart Diseases
• Congestive Heart Failure
• Congenital Heart Disease

Infectious Diseases

• Emerging Pathogens
• Multidrug Resistance

Neuroscience Disorders

• Multiple Sclerosis
• Stroke

Rare and Genetic Diseases

• Prevention Genomics
• Big Genetics Data Analysis and NGS
• Therapeutics Discovery

LATEST NEWS

 توقيع مذكرة تفاهم بين “كيمارك” بالشؤون الصحية بـوزارة الحرس الوطني والهيئة السعودية للبيانات والذكاء الاصطناعي (سدايا) على هامش قمة الرياض العالمية للتقنية الطبية، لدعم الجهود البحثية وجمع وتحليل البيانات الطبية

توقيع مذكرة تفاهم بين الشؤون الصحية بـوزارة الحرس الوطني ووزارة الاستثمار وأسترازينيكا على هامش قمة الرياض العالمية للتقنية الطبية، إتاحة الفرص للقطاع الصحي والشركات المحلية للاستفادة من مستجدات صناعة الأدوية

توقيع مذكرة تفاهم بين “كيمارك” بالشؤون الصحية بـوزارة الحرس الوطني ووزارة الصناعة والثروة المعدنية و شركة فايزر على هامش قمة الرياض العالمية للتقنية الطبية، لتحسين جودة الحياة من خلال تعزيز البحث العلمي والتدريب

توقيع ثلاث مذكرات تفاهم بين “كيمارك” بـالشؤون الصحية بوزارة الحرس الوطني وشركات متخصصة تهدف إلى تعزيز القدرات لتطوير اللقاحات والأجسام المضادة على هامش اليوم الثاني من قمة الرياض العالمية للتقنية الطبية ؛ لتطوير استراتيجيات الأبحاث في التقنية الطبية

MAJOR HIGHLIGHTS

3rd Therapeutic Discoveries Symposium: Insights from COVID-19 to Prevent And Cure Diseases – Hybrid
3rd Therapeutic Discoveries Symposium: Insights from COVID-19 to Prevent And Cure Diseases – Hybrid

February 22-24, 2022

How to Disseminate Your Results (Manuscript/Poster) Workshop – Virtual, March 17, 2022
How to Disseminate Your Results (Manuscript/Poster) Workshop – Virtual, March 17, 2022

March 17, 2022

KAIMRC Residents’ Research Program (RRP) – Virtual, Basic and Advance Module (Batch 12)
KAIMRC Residents’ Research Program (RRP) – Virtual, Basic and Advance Module (Batch 12)

November 28 – December 25, 2021

Residents’ Research Program (RRP) – Virtual, Basic and Advance Module (Batch 13)
Residents’ Research Program (RRP) – Virtual, Basic and Advance Module (Batch 13)

December 26, 2021 to January 22, 2022

Clinical Research Coordinator Training Program
Clinical Research Coordinator Training Program

September 5, 2021 to April 30, 2022

TOP AND LATEST PUBLICATIONS

TOP PUBLICATIONS

Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19

Journal:

New England Journal of Medicine

Impact Factor:

91.145

DOI:

10.1056/NEJMoa2105911

Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19

Journal:

New England Journal of Medicine

Impact Factor:

91.145

DOI:

10.1056/NEJMoa2103417

Interferon Beta-1b and Lopinavir-Ritonavir for Middle East Respiratory Syndrome

Journal:

The New England Journal of Medicine

Impact Factor:

74.699

DOI:

10.1056/NEJMoa2015294

Adjunctive Intermittent Pneumatic Compression for Venous Thromboprophylaxis

Journal:

New England Journal of Medicine

Impact Factor:

70.67

DOI:

10.1056/NEJMoa1816150.

Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

Journal:

Science

Impact Factor:

41.845

DOI:

10.1126/science.abd4570

Light-Powered Autonomous Flagella-Like Motion of Molecular Crystal Microwires

Journal:

Angewandte Chemie International Edition England

Impact Factor:

12.959

DOI:

10.1002/anie.202012417

Interferon Beta-1b and Lopinavir-Ritonavir for Middle East Respiratory Syndrome

Journal:

The New England Journal of Medicine

Impact Factor:

74.699

DOI:

10.1056/NEJMoa2015294

LATEST PUBLICATIONS

Seroprevalence of SARS-CoV-2 among High-Risk Healthcare Workers in a MERS-CoV Endemic Area

Journal:

Journal of Infection and Public Health

Impact Factor:

3.718

DOI:

10.1016/j.jiph.2021.08.029

Inhibition of Caffeine Metabolism by Apiaceous and Rutaceae Families of Plant Products in Humans: In Vivo and In Vitro Studies

Journal:

Frontiers in Pharmacology

Impact Factor:

5.810

DOI:

10.3389/fphar.2021.641090

Tele-pharmacy Anticoagulation Clinic During COVID-19 Pandemic: Patient Outcomes

Journal:

Frontiers in Pharmacology

Impact Factor:

5.810

DOI:

10.3389/fphar.2021.652482

RUNX1 mutation and elevated FLT3 gene expression cooperates to induce inferior prognosis in cytogenetically normal acute myeloid leukemia patients

Journal:

Saudi Journal of Biological Sciences

Impact Factor:

4.219

DOI:

10.1016/j.sjbs.2021.07.012

Predictors of poor precautionary practices towards COVID-19 among cancer patients

Journal:

Future Oncology

Impact Factor:

3.404

DOI:

10.2217/fon-2021-019

Prevention of gastrointestinal bleeding in critically ill patients

Journal:

Current Opinion in Critical Care

Impact Factor:

3.687

DOI:

10.1097/MCC.0000000000000803

Who should receive treatment? Healthcare professionals’ perspectives surrounding the medical management of patients with COVID-19

Journal:

Risk Management and Healthcare Policy

Impact Factor:

3.200

DOI:

10.2147/RMHP.S325312

STATISTICS

ASSOCIATED WEBSITES

CONTACT US

P.O. Box 3660, Riyadh 11481, Mail Code 1515 (KAIMRC)
Phone: +966 (11) 429-4444, Fax: +966 (11) 429-4440
Email: KAIMRC@NGHA.MED.SA